Sardor N. Azizov

Sardor N. Azizov

Auto-generated profile, based on publicly available information

Sardor N. Azizov

FSBI “Federal Center of Cardiovascular Surgery named after S.G.Sukhanov” of the MH RF

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2023 in Cardiac Arrhythmias
Verified
Journal Article
Open access
PDF file
VLVitaly V. Lyashenko
Vitaly V. Lyashenko
AIAndrey V. Ivanchenko
Andrey V. Ivanchenko
APAngelika S. Postol
Angelika S. Postol
SASardor N. Azizov
Sardor N. Azizov
AVAlexander B. Vygovsky
Alexander B. Vygovsky
ШАШнейдер Юрий Александрович
Шнейдер Юрий Александрович
BACKGROUND: Thoracoscopic version of the MAZE operation alone or in combination with catheter ablation (hybrid approach) has become widespread in the treatment of atrial fibrillation (AFib). However, recurrences of arrhythmias after such operations, in particular recurrence of AFib, remain unresolved problem. AIM: The aim of this study was to establish the structure of arrhythmia recurrence in patients with long-standing persistent AFib after primary epicardial ablation using the Dallas lesion set technique, as well as determining the optimal RFA strategy for recurrence. METHODS: 138 catheter ablation procedures for 100 patients, who applied with recurrence of various atrial arrhythmias after thoracoscopic MAZE. 34 patients had 2 or more RFA (31 pts 2, 2 pts 3, 1 pts 4). RESULTS: After Dallas lesion set thoracoscopic ablation in the structure of recurrences dominated: 1 AFib recurence; 2 incisional left atrial flutter. After the operation, a potential arrhythmogenic substrate remains, which must be fully eliminated by RFA (in addition to ablation the main cause of recurrence). This minimally necessary intervention implies: control and reisolation of the pulmonary veins; control and reisolation of the posterior wall; septal line from the mitral valve to the right superior pulmonary vein with Y-shaped branch to the left superior pulmonary vein; cava-tricuspid isthmus-blockade. This will eliminate and prevent in the future potentially possible incisional arrhythmias in fragmentary scars after thoracoscopic MAZE procedure. The return of AFib represents the most difficult group of patients. Restoration of sinus rhythm in recurrent AFib after epicardial ablation is possible, but may require extensive ablations in both atriums, as a result of repeated procedures, until all potential arrhythmia mechanisms, present in a particular patient, are eliminated. CONCLUSIONS: Catheter ablation remains the only method of effective treatment of recurrences after thoracoscopic MAZE procedure. The complexity and multicomponent nature of long-standing AFib causes the frequent need for repeated procedures, especially in cases of recurrence of atrial fibrillation.

7 May 2023 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
AKA. T. Kozhenov
A. T. Kozhenov
SAS. N. Azizov
S. N. Azizov
OKO. V. Khlynova
O. V. Khlynova
Aim. To assess the relationship between the left atrial (LA) and pul­monary vein (PV) effective refractory period and the development of early atrial fibrillation (AF) recurrence after radiofrequency pul­monary vein isolation (PVI).Material and methods. The study included 35 patients with persistent AF refractory to antiarrhythmic therapy (AAT). In all patients, LA and PV effective refractory period (ERP) was assessed, followed by radiofrequency antral PVI. Depending on the ERP values, the patients were divided into 2 groups. Group 1 (n=15) included patients with mean LA and PV ERP values ≥240 ms, while group 2 (n=20) consisted of patients with mean LA and PV ERP values <240 ms. The evaluation of early AF recurrence, depending on the obtained ERP values, was carried out in the first 3 months.Results. We obtained following ERP values: group 1 — LA (LA ap­ pendage) 252±8,9 ms; left superior PV (LSPV) — 252±12,1 ms; left inferior PV (LIPV) — 257,3±8,15 ms; right superior PV (RSPV) — 254,6±11,3 ms; right inferior PV (RIPV) — 260±9,05 ms; group 2 — LA 230±12,1 ms; LSPV — 205±10,5 ms; LIPV — 186,6±22,05 ms; RSPV — 212,2±14 ms; RIPV — 218,8±11,1 ms. During the 3-month follow-up of group 1 patients, there were no recurrences after PVI. Group 2 had 7 early AF recurrences. Correlation analysis revealed a significant inversely proportional relationship (-0,349; p=0,03) between ERP values and the recurrence rate in the groups.Conclusion. The first results demonstrate an inversely proportional relationship between the mean PV and LA ERP and the development of early AF recurrence, which makes it possible to consider the PV and LA ERP <240 ms as a likely predictor of early AF recurrence. However, this fact requires the study continuation with an increase in the sample and an appropriate statistical analysis.

4 December 2024 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
RKR. D. Khuziakhmetov
R. D. Khuziakhmetov
ESE. A. Shishkina
E. A. Shishkina
BKB. K. Kadyraliev
B. K. Kadyraliev
VBV. A. Belov
V. A. Belov
SAS. N. Azizov
S. N. Azizov
OKO. V. Khlynova
O. V. Khlynova
Atrial fibrillation (AF) is the most common arrhythmia among the adult population, affecting up to 2% of the population. Among patients with chronic heart failure (CHF), the prevalence of AF reaches 12.3%. The presence of common risk factors and pathophysiological mechanisms of AF and CHF development lead to the frequent combination of these two pathologies, which has a negative impact on the course of the underlying disease and further prognosis, increasing the chances of adverse outcomes such as stroke, myocardial infarction, and cardiovascular mortality. The results of most randomized studies indicate that interventional treatment of AF in patients with CHF and intermediate to low left ventricular ejection fraction (LV) contributes to reducing the functional class of CHF and improving quality of life, but at the same time, there is currently no consensus on the effectiveness, safety, and extent of catheter intervention. In this review, we attempted to summarize the literature data regarding the outcomes of interventional treatment of AF in patients with systolic LV dysfunction.

7 February 2025 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
SAS. N. Azizov
S. N. Azizov
RKR. D. Khuziakhmetov
R. D. Khuziakhmetov
VBV. A. Belov
V. A. Belov
AKA. T. Kozhenov
A. T. Kozhenov
VLV. V. Lyashenko
V. V. Lyashenko
Aim. Comparative evaluation of short-term and long-term outcomes of radiofrequency pulmonary vein isolation using the “Ablation Index” module versus without in patients with paroxysmal and persistent forms of atrial fibrillation.Methods. The study included 286 patients with paroxysmal and persistent forms of atrial fibrillation, divided into 2 groups: the study group (110 patients) underwent radiofrequency pulmonary vein isolation using the “Ablation Index” module, while the control group (176 patients) underwent isolation without the use of the “Ablation Index” module.Results. The average follow-up period was 38.1±9.6 months. There was no significant difference in freedom from atrial tachyarrhythmias in the long-term follow-up between the study and control groups (58.1% vs. 62.3%, p=0.667), or in the number of perioperative complications (3.6% vs. 8.5%, p=0.106). A significant reduction in the duration of the procedure was observed when using the “Ablation Index” module (92.7±20.9 min vs. 126.4±29.2 min, p<0.001), as well as in the recurrence rate of atrial fibrillation in the blanking period (1.8% vs. 8.5%, p=0.020).Conclusion. Interventional treatment of atrial fibrillation under the control of the “Ablation Index” module shows significantly lower recurrence rates of atrial tachyarrhythmias in the blanking period and comparable safety and long-term efficacy results compared to interventional treatment using catheters with contact force sensor over a period of more than three years.

5 September 2025 in Journal of Arrhythmology
Verified
Journal Article
Open access
PDF file
SAS. N. Azizov
S. N. Azizov
RKR. D. Khuziakhmetov
R. D. Khuziakhmetov
VLV. V. Lyashenko
V. V. Lyashenko
VBV. A. Belov
V. A. Belov
AKA. T. Kozhenov
A. T. Kozhenov
Aim. To compare immediate and long-term outcomes of catheter-based atrial fibrillation (AF) treatment following pulmonary vein (PV) cryoballoon ablation (CBA) using the second-generation cryoballoon and PV radiofrequency ablation (RFA) performed on the navigation system using the contact force-sensing catheter with the AI module.Methods. The study included 199 patients referred for PV isolation between 2018 and 2021. Patients were divided into two groups: the study group (n=110) underwent PV isolation via RFA using the catheter with the AI module; the control group (n=89) underwent PV CBA using the second-generation cryoballoon. The follow-up period was limited to 36 months, with a mean follow-up of 27.9 ± 14.2 months.Results. The three-year efficacy of CBA and RFA using the AI module was comparable (freedom from atrial tachy­ arrhythmias: RFA group 0.61±0.05, CBA group 0.62±0.05 (Log-Rank test, p = 0.896)), with similar complication rates and profiles (3.6% (n=4) vs. 4.5% (n=4), p=0.759). The AF recurrence rate during the blanking period was significantly lower in the RFA group using the AI module (1.8% (n=2) vs. 9.0% (n=8) in the CBA group, p=0.045). Procedure duration was significantly shorter in the cryoablation group (RFA 92.7±20.9 min, CBA 83.9±19.6 min, p=0.005). The need for repeat intervention was comparable between groups (RFA 21.8% (n=24), CBA 30.3% (n=27), p=0.171).Conclusion. Comparative analysis of the three-year efficacy of radiofrequency antral pulmonary vein isolation using the catheter with the “Ablation Index” (AI) module demonstrated results comparable to ablation with the secondgeneration cryoballoon. Furthermore, during the blanking period, the RFA group showed a statistically significant reduction in AF recurrence compared to the CBA group.

26 November 2025 in Clinical Medicine (Russian Journal)
Verified
Journal Article
Closed access
PDF file
RKR. D. Khuziahmetov
R. D. Khuziahmetov
ESE. A. Shishkina
E. A. Shishkina
BKB. K. Kadyraliev
B. K. Kadyraliev
VBV. A. Belov
V. A. Belov
SAS. N. Azizov
S. N. Azizov
OKO. V. Khlynova
O. V. Khlynova
Atrial fibrillation (AF) is a significant cause of chronic heart failure development. The results of randomized clinical trials focusing on interventional treatment of AF in patients with systolic left ventricular (LV) dysfunction demonstrate varying effectiveness and safety of catheter interventions. Objective. The main aim of this study is to evaluate the efficacy and safety of catheter ablation of AF in patients with systolic LV dysfunction compared to patients without systolic LV dysfunction. Material and methods. Following “pseudo-randomization” 395 patients who underwent pulmonary vein isolation were divided into 2 groups: the main group (LV ejection fraction < 50%, n = 42) and the comparison group (LV ejection fraction ≥ 50%, n = 81). Results. There was no statistically significant difference between the main group and the comparison group in the frequency of postoperative AF recurrence during hospitalization (7.1% (3) vs. 14.8% (12), p = 0.218), the frequency of intraoperative complications (2.4% vs. 9.9%, p = 0.130), and their structure (p = 0.442). The main group showed an increase in LV ejection fraction by +6.6 ± 7.9% on the 2nd day post-operation (p < 0.001), primarily due to the control of tachysystole and restoration of sinus rhythm in the presence of viable LV myocardium. Conclusion. Interventional treatment of AF in patients with systolic LV dysfunction is comparable in safety and efficacy to outcomes in cases with preserved LV ejection fraction.